Exscientia Stock (NASDAQ: EXAI) stock price, news, charts, stock research, profile.
Open | $5.000 |
Close | $4.610 |
Volume / Avg. | 311.305K / 744.342K |
Day Range | 4.570 - 5.000 |
52 Wk Range | 3.860 - 9.120 |
Market Cap | $593.961M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 7.2% |
Days to Cover | 7.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Exscientia (NASDAQ: EXAI) through any online brokerage.
Other companies in Exscientia’s space includes: Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT), CareDx (NASDAQ:CDNA) and Pharming (NASDAQ:PHAR).
The latest price target for Exscientia (NASDAQ: EXAI) was reported by Morgan Stanley on Monday, April 22, 2024. The analyst firm set a price target for 7.00 expecting EXAI to rise to within 12 months (a possible 48.94% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Exscientia (NASDAQ: EXAI) is $4.7 last updated May 10, 2024 at 6:23 PM EDT.
There are no upcoming dividends for Exscientia.
Exscientia’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Exscientia.
Exscientia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.